• Home
  • News
  • Analysis
  •  
    Regions
    • South Asia
    • North America
    • Europe
    • Central Asia
    • Australasia
    • MENA
    • Southeast Asia
    • Greater China
    • North Asia
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Credit
    • Early stage
    • PIPE
  •  
    Exits
    • Buyback
    • IPO
    • Open market
    • Trade sale
  •  
    Sectors
    • Real Estate
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Sectors

China chip designer Biren gets $410m Series B
China chip designer Biren gets $410m Series B

Biren Technology, a Chinese chip design company, has raised a RMB2.7 billion ($410 million) Series B round led by Ping An Insurance, New World Development, and Country Garden Venture Capital.

  • Greater China
  • 31 March 2021
IMM set for $222m exit from Korea's Taihan Electric Wire

IMM Private Equity has agreed to sell its 40% stake in Taihan Electric Wire, a Korea-based manufacturer of high-voltage cables to Hoban Construction for KRW251.8 billion ($222 million).

  • North Asia
  • 31 March 2021
Portfolio: GL Capital & SciClone Pharmaceuticals

GL Capital has helped China’s SciClone Pharmaceuticals position itself for the future while continuing to monetize its key legacy drug. A Hong Kong listing was the reward

  • Greater China
  • 30 March 2021
Deal focus: Rethinking Australia's biggest resource
Deal focus: Rethinking Australia's biggest resource

Adamantem Capital’s acquisition of carbon farming specialist Climate Friendly recognizes the increasing sophistication of the Australian carbon credit market as well as its room for improvement

  • Australasia
  • 30 March 2021
Fund focus: CityU promotes entrepreneur enablement
Fund focus: CityU promotes entrepreneur enablement

City University of Hong Kong plans to invest $64 million in creating 300 start-ups over the next three years, offering students and staff a more structured route to commercializing academic research

  • Greater China
  • 30 March 2021
Deal focus: Affinity to close JobKorea's technology gap

When Affinity Equity Partners was drawing up plans for JobKorea, it found Seek’s product innovations in Australia a useful reference point. This gave context to a $795 million acquisition

  • North Asia
  • 30 March 2021
Deal focus: IvyCap's timely 22x windfall
Deal focus: IvyCap's timely 22x windfall

With the launch of its third fund a few weeks away, IvyCap Ventures leveraged strong investor interest in beauty e-commerce player Purplle to secure one of India’s largest rupee VC exits

  • South Asia
  • 30 March 2021
Matrix leads Series E tranche for China corporate training platform

Matrix Partners China has led a second tranche of Series E funding - worth $90 million - for Yunxuetang, a Chinese online corporate training services provider.

  • Expansion
  • 30 March 2021
Redpoint China promotes Kyle Liu to partner
Redpoint China promotes Kyle Liu to partner

Redpoint China Ventures has promoted Kyle Liu, who focuses on early-stage enterprise services and cutting-edge technology investments, to partner level.

  • Greater China
  • 30 March 2021
VMS leads $190m round for China CDMO player Chime
VMS leads $190m round for China CDMO player Chime

VMS Group, a Hong Kong-based asset manager, has led a $190 million extended Series A round of funding for Chime Biologics, a Chinese contract development and manufacturing organization (CDMO).

  • Greater China
  • 30 March 2021
Wise Road agrees $1.4b take-private of Korea chipmaker
Wise Road agrees $1.4b take-private of Korea chipmaker

Wise Road Capital, a China-based private equity firm that focuses on high-tech investments, has agreed to privatize Korea’s Magnachip Semiconductor Corporation at a valuation of $1.4 billion.

  • Greater China
  • 30 March 2021
KKR joins $200m round for China coding education start-up

Hetao 101, a Chinese online education platform that provides computer programming courses for children, has raised $200 million in Series C funding led by KKR, Vision Plus Capital, and GL Ventures.

  • Greater China
  • 29 March 2021
Gulf Capital invests $30m in India healthcare push

Abu Dhabi-based Gulf Capital has committed $30 million to a plan that will see its global fertility services platform launch 18 clinics in India over the next 12 months.

  • South Asia
  • 29 March 2021
China's Baidu raises funding for chip unit at $2b valuation
China's Baidu raises funding for chip unit at $2b valuation

CPE has led a funding round for Kunlun, the semiconductor unit of Chinese search giant Baidu, at a post-deal valuation of approximately RMB13 billion ($2 billion).

  • Greater China
  • 29 March 2021
China's Zhihu completes $522m IPO, endures volatile debut
China's Zhihu completes $522m IPO, endures volatile debut

Chinese question-and-answer platform Zhihu endured a difficult New York Stock Exchange debut, closing at a 10.5% discount to its IPO price on a day when US-listed Chinese stocks fluctuated wildly.

  • Greater China
  • 28 March 2021
Australia social media start-up Linktree raises $45m
Australia social media start-up Linktree raises $45m

Index Ventures and Coatue Management have led a $45 million Series B round for Australia-based social media services platform Linktree.

  • Australasia
  • 28 March 2021
KKR, Sequoia lead $234m round for Indian NBFC
KKR, Sequoia lead $234m round for Indian NBFC

KKR and Sequoia Capital India have led a $234 million investment in Indian non-banking financial company (NBFC) Five Star Business Finance at a valuation of $1.4 billion.

  • South Asia
  • 28 March 2021
PE topples advisory as China Renaissance's key business

Fund management has become China Renaissance’s largest source of revenue, seven years after the firm – best known for providing private placement and M&A advisory services to Chinese internet companies – entered the private equity business.

  • Greater China
  • 28 March 2021
China yogurt brand secures $122m Series B
China yogurt brand secures $122m Series B

Simple Love, also known as Jian’Ai, a Chinese yogurt brand, has raised RMB800 million ($122 million) in Series B funding from Matrix Partners China, BA Capital, CITIC Agriculture Fund, and Maison Capital. They all backed the company's RMB400 million Series...

  • Greater China
  • 26 March 2021
China autonomous driving start-up TuSimple files for US IPO
China autonomous driving start-up TuSimple files for US IPO

TuSimple, a China and US-based developer of autonomous driving technology for trucks, has filed for a US IPO. Its backers include CDH Investments, Zhiping Capital, Sina Corporation, and Hong Kong hedge fund Composite Capital.

  • Greater China
  • 26 March 2021
India's Dream Sports raises $400m, hits $5b valuation
India's Dream Sports raises $400m, hits $5b valuation

Dream Sports, operator of India’s largest fantasy sports platform, has raised $400 million in funding led by TCV, D1 Capital Partners and Falcon Edge Capital. The post-deal valuation is nearly $5 billion.

  • South Asia
  • 26 March 2021
Hony launches China healthcare, consumer SPAC
Hony launches China healthcare, consumer SPAC

Hony Capital has joined a string of Chinese private equity managers with special purpose acquisition vehicles (SPACs), targeting $300 million for healthcare and consumer deals.

  • Greater China
  • 26 March 2021
JC Flowers exits Asia trading platforms business
JC Flowers exits Asia trading platforms business

JC Flowers has agreed to sell Hong Kong-based Chi-X Asia Pacific, which operates equity trading platforms in Australia and Japan, to US-based Cboe Global Markets.

  • Greater China
  • 25 March 2021
Invesco leads $155m round for China's Brii Biosciences

Invesco has led a $155 million Series C round for China-focused infectious diseases drug developer Brii Biosciences.

  • Greater China
  • 25 March 2021
124125126
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013